SH
SHFSW
SHF Holdings, Inc.
$0.0329
0.00%
$168.5K
No data for this timeframe.
Vol
Market Cap$168.5K
Cap SizeNano Cap
Inst. Holders5 funds
Inst. Value$13.5K
Inst. Activity0 buys / 2 sells
SEC Reports11
Recent Activity
May 28, 2026
SEC
SHF Holdings filed supplemental proxy materials (DEFA14A) highlighting the April 22 Board expansion from five to six mem
DEFA14A — Impact 2/10
May 18, 2026
SEC
SHF Holdings (SHFSW) reported Q1 2026 revenue of $1.98M, up 2.2% YoY, driven by a 55.6% surge in loan program income fro
8-K — Impact 5/10
May 11, 2026
SEC
SHF Holdings filed a DEFA14A supplement to correct a typographical error in its May 8, 2026 definitive proxy statement,
DEFA14A — Impact 1/10
Inst.
CITADEL ADVISORS LLC — TRIM
15,368 shares ($519.00)
Inst.
WOLVERINE ASSET MANAGEMENT LLC — TRIM
8,250 shares ($278.00)
Latest Reports
NEUTRAL
DEFA14A
2/10
SHF Holdings filed supplemental proxy materials (DEFA14A) highlighting the April 22 Board expansion from five to six mem
May 28, 2026
MIXED
8-K
5/10
SHF Holdings (SHFSW) reported Q1 2026 revenue of $1.98M, up 2.2% YoY, driven by a 55.6% surge in loan program income fro
May 18, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| Clear Street Group Inc. | $7.0K | — |
| D. E. Shaw & | $5.6K | — |
| CITADEL ADVISORS LLC | $356.00 | TRIM |
| MORGAN STANLEY | $309.00 | — |
| WOLVERINE ASSET MANAGEMENT LLC | $255.00 | TRIM |
5 institutional holders with $13.5K total value (443,579 shares) as of 2026-Q1. Top holders: Clear, D., CITADEL.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | Clear Street Group Inc. | 225,458 | $7.0K | 51.5% | — |
| 2 | D. E. Shaw & Co., Inc. | 188,000 | $5.6K | 41.7% | — |
| 3 | CITADEL ADVISORS LLC | 11,871 | $356.00 | 2.6% | TRIM -31.4% |
| 4 | MORGAN STANLEY | 10,000 | $309.00 | 2.3% | — |
| 5 | WOLVERINE ASSET MANAGEMENT LLC | 8,250 | $255.00 | 1.9% | TRIM -57.6% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | TRIM | 22,390 | 15,368 | -31.4% | $519.00 | 2025-Q3 |
| WOLVERINE ASSET MANAGEMENT LLC | TRIM | 19,467 | 8,250 | -57.6% | $278.00 | 2025-Q3 |
| UBS Group AG | DOUBLED | 310 | 1,852 | +497.4% | $80.00 | 2024-Q4 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
11 SEC filing reports analyzed. Sentiment: 0 bullish, 3 bearish, 3 mixed, 5 neutral. Avg impact: 4.4/10.
NEUTRAL
DEFA14A
2/10
SHF Holdings filed supplemental proxy materials (DEFA14A) highlighting the April 22 Board expansion
May 28, 2026
MIXED
8-K
5/10
SHF Holdings (SHFSW) reported Q1 2026 revenue of $1.98M, up 2.2% YoY, driven by a 55.6% surge in loa
May 18, 2026
NEUTRAL
DEFA14A
1/10
SHF Holdings filed a DEFA14A supplement to correct a typographical error in its May 8, 2026 definiti
May 11, 2026
NEUTRAL
3
2/10
Two late Form 3 filings were submitted on May 8, 2026, reporting initial beneficial ownership for ne
May 9, 2026
BEARISH
S-1
6/10
SHF Holdings files S-1 to register 22.6M shares for resale by existing stockholders, including 21.5M
May 6, 2026
BEARISH
8-K
6/10
SHF Holdings voluntarily reduced the conversion price of its Series B Preferred Stock and the exerci
May 6, 2026
NEUTRAL
8-K
3/10
SHF Holdings announced the expansion of its lending platform for cannabis-related businesses, adding
Apr 30, 2026
BEARISH
8-K
8/10
SHF Holdings received a Nasdaq delisting notice for failing to maintain a $1.00 minimum bid price, a
Apr 24, 2026
MIXED
8-K
6/10
SHF Holdings reported preliminary unaudited financial results for Q4 and full year 2025, showing a 5
Apr 21, 2026
NEUTRAL
8-K
3/10
SHF Holdings, Inc. launched the Safe Harbor Retirement Plan, a pooled employer 401(k) plan tailored
Apr 21, 2026
MIXED
8-K
6/10
SHF Holdings reported full-year 2025 revenue of $7.67 million (down from $15.24 million in 2024) and
Apr 21, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.